4//SEC Filing
GANNON STEVEN 4
Accession 0000950170-24-028788
CIK 0001582313other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:28 PM ET
Size
19.2 KB
Accession
0000950170-24-028788
Insider Transaction Report
Form 4
GANNON STEVEN
Director
Transactions
- Sale
Common Shares
2024-03-07$46.45/sh−1,000$46,450→ 14,000 total - Sale
Common Shares
2024-03-07$46.30/sh−5,000$231,513→ 4,000 total - Sale
Common Shares
2024-03-07$46.25/sh−5,000$231,250→ 9,000 total - Sale
Common Shares
2024-03-07$46.20/sh−2,000$92,402→ 2,000 total
Footnotes (2)
- [F1]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.3025 to $46.3675, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F2]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.20 to $46.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001643085
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 5:28 PM ET
- Size
- 19.2 KB